GOSS
Gossamer Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.18
−0.17%Leverage
- Debt / equity
- -0.42x
- Net debt / equity
- 0.02x
- Debt / assets
- 0.51x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- 0.01x
Liquidity & coverage
- Current ratio
- 0.53x
- Quick ratio
- 0.53x
- Cash ratio
- 0.41x
- Interest coverage
- -15.16x
- EBITDA / interest
- -18.70x
- Working capital
- -$65.1M
Cash & dividend
- FCF / debt
- -4.16x
- Cash flow / debt
- -4.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026